AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Harglim M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Harleys Healthcare Pvt. Ltd.

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Harglim M2 Tablet SR

Diabexe Duo SR tablets are an antidiabetic medication combining two active agents for adult type 2 diabetes management. This dual-action formulation helps regulate blood glucose. Diabexe Duo SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical guidance can elevate glucose levels, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods, fruit juice) is essential. Alcohol consumption elevates hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may occur. Diabexe Duo SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before starting treatment. Pregnant or lactating individuals must consult their doctor. Regular blood glucose monitoring, along with periodic blood tests (blood cell counts and liver function), is recommended.

Primary Ingredients of Harglim M2 Tablet SR

No information provided. A rephrased version cannot be provided.

Uses of Harglim M2 Tablet SR

Managing type 2 diabetes

Major Benefits of Harglim M2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Harglim M2 Tablet SR with a meal.

Common Side effects of Harglim M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Harglim M2 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the Harglim M2 Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be taken with food.

How Harglim M2 Tablet SR works:

Harglim M2 SR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to produce more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing the liver's glucose output, slowing glucose absorption in the gut, and improving the body's response to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Harglim M2 Tablet SR and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Harglim M2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Harglim M2 SR tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose is abnormally high or low. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Harglim M2 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Harglim M2 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. In individuals with mild to moderate hepatic dysfunction, Harglim M2 Tablet SR therapy typically begins with a reduced dose; however, it's contraindicated in those with severe liver disease.

What if you forget to take Harglim M2 Tablet SR :

Should you forget a Harglim M2 Tablet SR dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Harglim M2 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Harglim M2 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Harglim M2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. If you experience these symptoms, discontinue Harglim M2 Tablet SR and seek immediate medical attention.
Harglim M2 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and regular physical activity. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Harglim M2 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Harglim M2 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Harglim M2 Tablet SR can indeed lower blood sugar (cause hypoglycemia), leading to symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other diabetes medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Harglim M2 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Harglim M2 Tablet SR
69
MRP 80
13% off